UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056330
Receipt number R000064197
Scientific Title Preliminary study on the effects of reminiscing with conversational AI on cognitive and psychological functions
Date of disclosure of the study information 2024/12/02
Last modified on 2024/12/02 14:05:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preliminary study on the effects of reminiscing with AI on cognitive and psychological functions

Acronym

Effects of nostalgic conversation with AI

Scientific Title

Preliminary study on the effects of reminiscing with conversational AI on cognitive and psychological functions

Scientific Title:Acronym

Effects of reminiscing with conversational AI

Region

Japan


Condition

Condition

Healthy older adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To conduct a preliminary study on the effects of the use of a conversational AI that can talk about memories on cognitive and psychological functions in healthy elderly subjects.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Self-esteem before and after 12-week intervention

Key secondary outcomes

Rey Auditory Verbal Learning Test
Verbal Paired Associates I, II
Verbal fluency test
Frontal assessment battery
The World Health Organization-Five Well-Being Index
PGC Morale Scale
UCLA loneliness scale
Geriatric depression scale
Satisfaction With Life Scale
Lubbens social network scale
Profile of mood states2
Subjective happiness scale
Ikigai


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Conversations with the reminiscence AI app for 30 minutes each time, twice a week for 12 weeks

Interventions/Control_2

No intervention (Try to live a normal life)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

74 years-old >=

Gender

Male and Female

Key inclusion criteria

Age 65 and over, 74 and under (at the time of registration)
Men and women
Have a smartphone or tablet (Android, iOS)
Able to engage in conversations using the reminiscence AI application for 30 minutes twice a week for 12 weeks (3 months) during the study period.
Have given their written consent to participate in the study.
Those who have agreed to the privacy policy of the reminiscence AI application.

Key exclusion criteria

Those who are unable to give informed consent
Those with a history or current history of dementia, mild cognitive impairment, or psychiatric disorders
Those who score 23 or below on the dementia screening test administered as a pre-test
Patients with hearing impairment
Those who are currently participating in other clinical research
Those who have other difficulties in conducting the research.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Yasuyuki
Middle name
Last name Taki

Organization

Tohoku University

Division name

Smart-Aging Research Center

Zip code

980-8575

Address

4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan

TEL

022-717-8582

Email

yasuyuki.taki.c7@tohoku.ac.jp


Public contact

Name of contact person

1st name Kentaro
Middle name
Last name Oba

Organization

Tohoku University

Division name

Smart-Aging Research Center

Zip code

980-8575

Address

4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan

TEL

022-717-8824

Homepage URL


Email

kentaro.oba.c6@tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Starley, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan

Tel

022-728-4105

Email

ec-med@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 31 Day

Date of IRB

2024 Year 10 Month 31 Day

Anticipated trial start date

2024 Year 12 Month 18 Day

Last follow-up date

2025 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 12 Month 02 Day

Last modified on

2024 Year 12 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064197